1 Introduction Cancer remains one of the leading causes of death worldwide, with most patients ultimately dying from metastatic disease [1]. Surgery is a cornerstone in the management of solid tumours, with an estimated 60%–80% of cancer patients requiring surgery during the course of their disease [2, 3]. However, both surgical trauma and anaesthetic agents can alter and suppress the immune system, creating a perioperative environment that favours tumour persistence and metastatic spread [4-6].